No article text was recorded for this version.
immunosuppression-infection tradeoff
Version 2 of 2103 papers141 conceptsfrozen 2026-10-04
Papers in this version
- Blog: IL-15 Superagonist Expands mCD8+ T, NK and NKT Cells after Burn Injury but Fails to Improve Outcome during Burn Wound Infection
- Blog: Postoperative Management and Complications in Living-related Liver Transplantation
- Blog: Central nervous system Aspergillus fumigatus infection with subarachnoid haemorrhage secondary to hemophagocytic lymphohistiocytosis: a rare case report
- Blog: Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing Rheumatologist
- Blog: Immunosuppression in living donor liver transplantation from ABO blood type incompatible donors
- Blog: Interleukin-37 in respiratory diseases: molecular mechanisms and immune modulation
- Blog: Corticosteroids treatment in severe patients with COVID-19: a propensity score matching study
- Blog: Rapidly Progressive Glomerulonephritis Concomitant with Diabetic Nephropathy.
- Blog: Complement updates in optic neuritis
- Blog: Negative Regulator Nlrc3-like Maintain the Balanced Innate Immune Response During Mycobacterial Infection in Zebrafish
- Blog: MyD88 and TLR9 Dependent Immune Responses Mediate Resistance to Leishmania guyanensis Infections, Irrespective of Leishmania RNA Virus Burden
- Blog: A combination of Interferon Stimulated Genes is more effective than IFNα and IFNβ in reducing HIV-1 replication in human cervicovaginal tissues
- Blog: Hematopoietic stem cell transplantation in children with acute leukemia: similar outcomes in recipients of umbilical cord blood versus marrow or peripheral blood stem cells from related or unrelated donors
- Blog: Efficacy and safety of calcineurin inhibitors (CNIs) for septic patients in ICU: A cohort study from MIMIC database
- Blog: Therapy with Biologic Agents After Diagnosis of Solid Malignancies: Results from the Corrona Registry
- Blog: A pilot study showing a stronger H1N1 influenza vaccination response during pregnancy in women who subsequently deliver preterm
- Blog: Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 1: Preexisting Inflammatory Arthritides
- Blog: Infectious events in patients with severe COVID-19: results of a cohort of patients with high prevalence of underlying immune defect
- Blog: C‑reactive protein and cardiovascular disease: From animal studies to the clinic (Review)
- Blog: Neutrophil extracellular traps mediate deep vein thrombosis: from mechanism to therapy
- Blog: LPS promotes the production of ROS in neutrophils to regulate their killing activity against Mycobacterium tuberculosis
- Blog: A Phenome-Wide Association Study of genes associated with COVID-19 severity reveals shared genetics with complex diseases in the Million Veteran Program
- Blog: Immunomodulatory Effects of Umbilical Cord Mesenchymal Stem Cells in Acute Graft-Versus-Host Disease
- Blog: Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases
- Blog: Safety and immune cell kinetics after donor natural killer cell infusion following haploidentical stem cell transplantation in children with recurrent neuroblastoma
- Blog: Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases
- Blog: Efficacy and safety of calcineurin inhibitors (CNIs) for septic patients in ICU: a cohort study from MIMIC database
- Blog: Neutrophil Extracellular Traps in Sepsis and Sepsis-Related Organ Dysfunction
- Blog: Advances in Immunotherapy for Type 1 Diabetes
- Blog: mPGES-1-Mediated Production of PGE2 and EP4 Receptor Sensing Regulate T Cell Colonic Inflammation
- Blog: [Short-term substitution of calcineurin inhibitors (CNI) with recombinant humanized anti-CD25 monoclonal antibody (Basiliximab) as aGVHD prophylaxis in CNI intolerant patients after allogeneic hematopoietic stem cell transplantation].
- Blog: Canadian Rheumatology Association/Canadian Research Group of Rheumatology in Immuno-Oncology Living Guidelines for Baseline Immunosuppression in Individuals With Preexisting Rheumatic Diseases Initiating Immune Checkpoint Inhibitors. Part 2: Preexisting Systemic Autoimmune Rheumatic Diseases
- Blog: Improved survival over time with immunotherapy in locally advanced and metastatic cutaneous squamous cell carcinomas
- Blog: Senescence-induced p21high macrophages contributed to CD8+ T cells-related immune hyporesponsiveness in kidney transplantation via Zfp36/IL-27 axis
- Blog: Individualized Constellation of Killer Cell Immunoglobulin-Like Receptors and Cognate HLA Class I Ligands that Controls Natural Killer Cell Antiviral Immunity Predisposes COVID-19
- Blog: Cross-talk between the airway epithelium and activated immune cells defines severity in COVID-19
- Blog: POS1246 COVID-19 IN RITUXIMAB TREATED PATIENTS WITH INFLAMMATORY RHEUMATIC DISEASES
- Blog: Co-Reactivation of Cytomegalovirus and Epstein-Barr Virus Was Associated With Poor Prognosis After Allogeneic Stem Cell Transplantation
- Blog: Clinical characteristics and corticosteroids application of different clinical types in patients with corona virus disease 2019
- Blog: From Severe Herpes Zoster to Rare Suid Herpesvirus Encephalitis: A New Twist of the <i>Varicellovirus</i> Genus Infection in Patients with Kidney Diseases
- Blog: Bridging inflammation and venous thrombosis: the NLRP3 inflammasome connection
- Blog: Influencing factors of virus duration and virus clearance in COVID-19 patients in Shenzhen: A retrospective study.
- Blog: The Association Between Alpha-1 Adrenergic Receptor Antagonists and In-Hospital Mortality from COVID-19
- Blog: POS1567 OUTCOMES AND PREDICTORS OF CHRONIC IMMUNE CHECKPOINT INHIBITOR INDUCED INFLAMMATORY ARTHRITIS: DATA FROM THE CANADIAN RESEARCH GROUP OF RHEUMATOLOGY IN IMMUNO-ONCOLOGY (CANRIO) RETROSPECTIVE COHORT
- Blog: Mononuclear phagocyte system blockade for enhanced liposome-assisted metabolic glycan labeling and circulating biomarker detection in mice
- Blog: [Impact of immunosuppression intensified conditioning regimen for patients with strong positive pre-transplantation donor-specific anti-HLA antibodies (DSAs) undergoing haploidentical hematopoietic stem cell transplantation].
- Blog: Hydroxychloroquine is associated with slower viral clearance in clinical COVID-19 patients with mild to moderate disease: A retrospective study
- Blog: Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity
- Blog: Initial stage of crusted scabies and possible diagnostic characteristics: A case series
- Blog: hIgD-Fc-Ig fusion protein regulate T cell functions by inhibiting TCR signaling pathway in adjuvant arthritis rats
- Blog: Effect of a combination of Xuebijing and thymosin α1 on patients with severe pneumonia complicated with sepsis, and its influence on serum inflammatory factors
- Blog: Adult-onset Still’s disease during pregnancy: two case reports and a comprehensive literature review
- Blog: Evaluating the efficacy of basiliximab versus no induction in low-immunological-risk kidney transplant recipients: a propensity score matched analysis
- Blog: A Comprehensive Landscape of De Novo Malignancy After Double Lung Transplantation
- Blog: Corticosteroids for infectious critical illness: A multicenter target trial emulation stratified by predicted organ dysfunction trajectory
- Blog: Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in Multiple Myeloma
- Blog: Disease-associated immune cell endotypes in anti-MDA5-positive dermatomyositis using unbiased hierarchical clustering
- Blog: Inflammasome activation in infected macrophages drives COVID-19 pathology
- Blog: Options for tracking GFP-Labeled transplanted myoblasts using in vivofluorescence imaging: implications for tracking stem cell fate
- Blog: Targeting early changes in the synovial microenvironment: a new class of immunomodulatory therapy?
Showing 60 of 103 papers.
History & citation
Current · Permanent link
Cite this direction
Latest version (a living page):
@misc{lacuna_immunosuppression_infection_tradeoff_c7d1364c,
title = {immunosuppression-infection tradeoff},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/immunosuppression-infection-tradeoff/rdr_c7d1364cca0d43769b498894df146b24},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-19},
}This exact version (version 2, frozen text):
@misc{lacuna_immunosuppression_infection_tradeoff_c7d1364c_v2,
title = {immunosuppression-infection tradeoff},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/immunosuppression-infection-tradeoff/rdr_c7d1364cca0d43769b498894df146b24/v/2},
note = {Version 2, frozen 2026-10-04. Accessed 2026-11-19},
}